Brady (BRC) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
27 Dec, 2025Executive summary
Achieved record adjusted diluted EPS of $1.22 in Q3 FY2025, up 11.9% year-over-year, with organic sales growth of 1.6% and acquisition-driven growth of 10.5%, bringing total Q3 sales to $382.6 million.
Net income for Q3 was $52.3 million, up 2.7% year-over-year; adjusted net income was $58.8 million, up 11.6%.
Americas & Asia delivered strong organic sales growth of 5.4% and segment profit up 15% (22.5% margin), while Europe & Australia saw a 5.4% organic sales decline but improved adjusted operating income by 3.8% due to restructuring.
Acquisitions of Gravotech, AB & R, and Funai's microfluidic solution business expanded product offerings and contributed to sales growth.
Maintained strong liquidity with $152.2 million in cash and $195.2 million available under the credit agreement as of April 30, 2025.
Financial highlights
Adjusted diluted EPS rose 11.9% year-over-year to $1.22, a new record; GAAP diluted EPS was $1.09.
Total sales grew 11.4% to $382.6 million, with acquisitions contributing 10.5% and foreign currency reducing sales by 0.7%.
Gross profit margin was 51%, down from 51.6% last year, mainly due to tariffs and acquisition-related costs.
Operating cash flow for Q3 was $59.9 million; nine-month cash from operations was $122.9 million, both down year-over-year due to working capital changes.
Returned $44.5 million to shareholders in Q3 via dividends and buybacks; $104.6 million remained under the repurchase program.
Outlook and guidance
Tightened adjusted diluted EPS guidance for FY2025 to $4.48–$4.63 per share; GAAP EPS guidance updated to $3.95–$4.10.
Expecting low single-digit organic sales growth for the year ending July 31, 2025.
Guidance assumes a 20% tax rate, $40 million in depreciation/amortization, and $25 million in capital expenditures.
Tariffs expected to impact Q4 by $3–$5 million, net of mitigation.
Management expects the annual income tax rate to remain around 21% based on current global business mix and tax laws.
Latest events from Brady
- Record earnings, robust innovation, and global expansion drive strong long-term growth outlook.BRC
Sidoti March Small-Cap Virtual Conference19 Mar 2026 - Raised EPS guidance after strong sales and profit growth; 20th straight quarter of organic gains.BRC
Q2 202619 Feb 2026 - Record profitability and innovation drive growth, supported by strong cash flow and global expansion.BRC
Small-Cap Growth Virtual Investor Conference3 Feb 2026 - Record EPS, strong cash flow, and Gravotech acquisition set stage for continued growth.BRC
Q4 202422 Jan 2026 - Record EPS, strong cash flow, and global growth fueled by innovation and disciplined investment.BRC
Sidoti September Small-Cap Virtual Conference20 Jan 2026 - Adjusted EPS up 12% and sales up 13.6%, with guidance reaffirmed for fiscal 2025.BRC
Q1 202513 Jan 2026 - Record adjusted EPS and double-digit sales growth, with strong FY2026 outlook.BRC
Q4 202531 Dec 2025 - Record earnings, strong cash flow, and innovation fuel growth and global expansion.BRC
Sidoti Small-Cap Virtual Conference26 Dec 2025 - Q2 FY2025 Adjusted EPS up 7.5%, guidance raised, strong cash flow and liquidity.BRC
Q2 202523 Dec 2025